1. Home
  2. BBWI vs ALKS Comparison

BBWI vs ALKS Comparison

Compare BBWI & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBWI
  • ALKS
  • Stock Information
  • Founded
  • BBWI 1963
  • ALKS 1987
  • Country
  • BBWI United States
  • ALKS Ireland
  • Employees
  • BBWI N/A
  • ALKS N/A
  • Industry
  • BBWI Clothing/Shoe/Accessory Stores
  • ALKS Biotechnology: Pharmaceutical Preparations
  • Sector
  • BBWI Consumer Discretionary
  • ALKS Health Care
  • Exchange
  • BBWI Nasdaq
  • ALKS Nasdaq
  • Market Cap
  • BBWI 5.8B
  • ALKS 4.9B
  • IPO Year
  • BBWI N/A
  • ALKS 1991
  • Fundamental
  • Price
  • BBWI $26.07
  • ALKS $28.26
  • Analyst Decision
  • BBWI Buy
  • ALKS Strong Buy
  • Analyst Count
  • BBWI 15
  • ALKS 14
  • Target Price
  • BBWI $39.57
  • ALKS $41.29
  • AVG Volume (30 Days)
  • BBWI 7.2M
  • ALKS 1.9M
  • Earning Date
  • BBWI 08-28-2025
  • ALKS 10-23-2025
  • Dividend Yield
  • BBWI 3.11%
  • ALKS N/A
  • EPS Growth
  • BBWI N/A
  • ALKS 21.99
  • EPS
  • BBWI 3.38
  • ALKS 2.08
  • Revenue
  • BBWI $7,371,000,000.00
  • ALKS $1,505,296,000.00
  • Revenue This Year
  • BBWI $4.15
  • ALKS N/A
  • Revenue Next Year
  • BBWI $2.94
  • ALKS $1.66
  • P/E Ratio
  • BBWI $7.61
  • ALKS $13.19
  • Revenue Growth
  • BBWI N/A
  • ALKS N/A
  • 52 Week Low
  • BBWI $24.94
  • ALKS $25.17
  • 52 Week High
  • BBWI $41.87
  • ALKS $36.45
  • Technical
  • Relative Strength Index (RSI)
  • BBWI 34.28
  • ALKS 50.86
  • Support Level
  • BBWI $25.63
  • ALKS $26.40
  • Resistance Level
  • BBWI $26.66
  • ALKS $28.65
  • Average True Range (ATR)
  • BBWI 1.08
  • ALKS 1.14
  • MACD
  • BBWI -0.40
  • ALKS -0.12
  • Stochastic Oscillator
  • BBWI 5.75
  • ALKS 47.85

About BBWI Bath & Body Works Inc.

Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with just 5% of sales from international markets in fiscal 2024. For fiscal 2024, 76% of sales stemmed from the brick-and-mortar network (which was composed of more than 1,800 retail stores), similar to 2023 levels, as consumer shopping patterns remained to normal. Future growth is expected from store upgrades, digital and international channels, as well as adjacent category expansions like hair and laundry.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: